Patentes:
Method and means for diagnosing and treating allergy
Method and means for diagnosing and treating allergy
Año:2013
Áreas de investigación
-
Biología molecular, celular y genética
Datos
|
Descripción
|
|
|---|---|
| The present invention relates to the use of neutrophil gelatinase-associated lipocalin (NGAL=LCN2=24p3) as a diagnostic tool for alelrgy and as a therapeutic method of treating, reducing, or ameliorating clinical manifestations of allergic disease. The invention includes measurement of NGAL levels in body fluids such as serum/plasma/saliva/blood and urin to determine sensitization state in allergic human and pet individuals. Moreover, it includes administering to the patient NGAL or lipocalin allergens in an amount effective to treat, reduce or ameliorate allergic disease. A siderophore can be co-administered with the NGAL or lipocalin allergen. The invention also relates to administering a siderophore-iron complex for allergen immunotherapy. | |
|
Internacional
|
Si |
|
Estado
|
Solicitada |
|
Referencia Patente Prioritaria
|
EP 14150965.3. |
|
En explotación
|
No |
|
Licenciatarios
|
|
|
Fecha solicitud
|
17/07/2013 |
|
Titulares aparte de la UPM
|
|
Participantes
- Autor: Araceli Diaz Perales (UPM)
- Autor: Luis Fernandez Pacios (UPM)
- Autor: Cristina Gomez Casado (UPM)
- Autor: F Roth-Walter
- Autor: E Jensen-Jarolim
Grupos de investigación, Departamentos, Centros e Institutos de I+D+i relacionados
- Creador: Grupo de Investigación: Biotecnología de Proteínas Vegetales
S2i 2023 Observatorio de investigación @ UPM con la colaboración del Consejo Social UPM
Cofinanciación del MINECO en el marco del Programa INNPACTO (IPT-020000-2010-22)